Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT.
Thwaites, G. E. [et al]
JournalHealth technology assessment (Winchester, England)
Randomized Controlled Trial
RightsArchived with thanks to Health technology assessment (Winchester, England)
MetadataShow full item record
Staphylococcus aureus bacteraemia is a common and frequently fatal infection. Adjunctive rifampicin may enhance early S. aureus killing, sterilise infected foci and blood faster, and thereby reduce the risk of dissemination, metastatic infection and death.